Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Tax Provisions (2018 - 2022)

Historic Tax Provisions for Regenxbio (RGNX) over the last 5 years, with Q4 2022 value amounting to -$43000.0.

  • Regenxbio's Tax Provisions fell 10032.08% to -$43000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$84000.0, marking a year-over-year decrease of 10062.65%. This contributed to the annual value of -$152000.0 for FY2023, which is 8095.24% down from last year.
  • Per Regenxbio's latest filing, its Tax Provisions stood at -$43000.0 for Q4 2022, which was down 10032.08% from -$41000.0 recorded in Q1 2022.
  • Over the past 5 years, Regenxbio's Tax Provisions peaked at $13.4 million during Q4 2021, and registered a low of -$2.4 million during Q4 2019.
  • For the 5-year period, Regenxbio's Tax Provisions averaged around $1.4 million, with its median value being -$22000.0 (2020).
  • In the last 5 years, Regenxbio's Tax Provisions skyrocketed by 34019.24% in 2020 and then crashed by 112500.0% in 2022.
  • Quarter analysis of 5 years shows Regenxbio's Tax Provisions stood at $1.6 million in 2018, then tumbled by 247.5% to -$2.4 million in 2019, then soared by 340.19% to $5.7 million in 2020, then soared by 133.38% to $13.4 million in 2021, then crashed by 100.32% to -$43000.0 in 2022.
  • Its last three reported values are -$43000.0 in Q4 2022, -$41000.0 for Q1 2022, and $13.4 million during Q4 2021.